Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee.
| Author | |
|---|---|
| Abstract |
:
Flavocoxid is a novel flavonoid-based "dual inhibitor" of the 5-lipoxygenase (5-LOX) enzyme and the cyclooxygenase (COX) enzymes. This study was designed to compare the effectiveness and safety of flavocoxid to naproxen in subjects with moderate to severe osteoarthritis (OA) of the knee. |
| Year of Publication |
:
2010
|
| Journal |
:
Advances in therapy
|
| Volume |
:
27
|
| Issue |
:
10
|
| Number of Pages |
:
731-42
|
| ISSN Number |
:
0741-238X
|
| URL |
:
http://dx.doi.org/10.1007/s12325-010-0064-z
|
| DOI |
:
10.1007/s12325-010-0064-z
|
| Short Title |
:
Adv Ther
|
| Download citation |
